Metastasis-associated genes and metastatic tumor progression

In Vivo

Volumn 12, Issue 6, 1998, Pages 579-588

  Nicolson, Garth L ^a   Moustafa, Amr S ^b  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Cancer progression; Genes; Metastasis

Indexed keywords

BREAST CELL; CANCER GENETICS; CANCER GROWTH; CELL COMMUNICATION; CELL MOTILITY; GENE EXPRESSION; GENE STRUCTURE; METASTASIS; ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032423358     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Nowell PC: The clonal evolution of tumor cell populations. Science 194:23-28, 1976.
2. Nicolson GL: Tumor cell instability, diversification and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 47: 1473-1487, 1987.
3. Nicolson GL: Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr Opin Oncol 3: 75-92, 1991.
4. Nicolson GL: Quantitative variations in gene expression: Possible role in cellular diversification and tumor progression. J. Cell Biochem 46: 277-283, 1991.
5. Nicolson GL: Gene expression and tumor progression to the metastatic phenotype. Bioessays 13: 337-342, 1991.
6. Moustafa AS and Nicolson GL: Breast cancer metastasis-associated genes: Prognostic significance and therapeutic implications. Oncol Res 9: 505-525, 1997.
7. Volpe JPG: Genetic instability of cancer. Why a metastatic tumor is unstable and a benign tumor is stable. Cancer Genet Cytogenet 34: 125-134, 1988.
8. Miller FR and Heppner GH: Cellular implications in metastasis. Cancer Metastasis Rev 9: 21-34, 1990.
9. Trosko JE Madhukar BV and Chang CC: Endogenous and exogenous modulation of gap junctional intercellular communication: Toxicological and pharmacological implications. Life Sciences 53: 1-19, 1993.
10. Nicolson GL, Lichtner RB and Trosko JE: Cytoskeletal and junctional heterogeneity in mammary tumor cells and their possible significance in tumor progression. In: Cancer Metastasis: Biological and Biochemical Mechanisms and Clinical Aspects (Prodi G, Liotta LA, Lollini PL, Garbisa S, Gorini S and Hellmann K. eds). Plenum, New York, 1988. pp 21-26.
11. Nicolson GL: Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1: 1009-1019, 1989.
12. Nicolson GL: Paracrine/autocrine growth mechanisms in tumor metastasis. Oncology Res 4: 389-399, 1993.
13. Foulds L: In Neoplastic Development, Academic Press, New York, 1975.
14. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
15. Heppner GH: Tumor heterogeneity. Cancer Res 44: 2259-2265, 1984.
16. Rubin H: The significance of biological heterogeneity. Cancer Metastasis Rev 9: 1-20, 1990.
17. Frost P and Chernajovsky Y: Transformation injury and the unicellular phenotype of malignant cells. Cancer Metastasis Rev 9: 93-98, 1990.
18. Kerbel RA, Waghorne C and Korczak B: Clonal dominance of primary tumors by metastatic cells: Genetic analysis and biological implications. Cancer Surv 7: 597-629, 1988.
19. Armstrong PB: In Invasion: Experimental and Clinical Implications, Oxford University Press, Oxford, pp 126-167, 1984.
20. Klein G and Klein E: Conditional tumorigenicity of activated oncogenes. Cancer Res 46: 3211-3224, 1986.
21. Hanahan D: Transgenic mice as probes into complex systems. Science 246: 1265-1275, 1989.
22. Gitelman I, Dexter DF and Roder JC: DNA amplification and metastasis of the human melanoma cell line MeWo. Cancer Res 47: 3851-3855, 1987.
23. Ha proto-oncogenes in cancers are frequent and show clinical. correlation. Science 231: 261-265, 1986.
24. Chambers AF and Tuck AB: Oncogene transformation and the metastatic phenotype. Anticancer Res 8: 861-872, 1988.
25. Muschel R and Liotta LA: Role of oncogenes in metastasis. Carcinogenesis 9: 705-710, 1988.
26. Greenberg AH, Egan SE and Wright JA: Oncogenes and metastatic progression. Invasion Metastasis 9: 360-378, 1989.
27. Tuck AB, Wilson SM and Chambers AF: ras transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cells. Clin Exp Metastasis 8: 417-431, 1990.
28. EJ or neo genes. Oncogene 5: 747-753, 1990.
29. Kerbel RS, Waghorne C and Man MS: Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Proc Natl Acad Sci USA 84: 1263-1267, 1987.
30. Muschel RJ and McKenna WG: Oncogenes and tumor progression. Anticancer Res 9: 1395-1406, 1989.
31. Egan SE, McClarty GA and Wright JA: Expression of H-ras-transformed 10T1/2 fibroblasts. Mol Cell Biol 7: 830-837, 1987.
32. Kyprianou N and Isaacs JT: Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with v-H-ras oncogene. Cancer Res 50: 1449-1454, 1990.
33. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
34. Sidebottom E and Clark SR: Cell fusion segregates progressive growth from metastasis. Br J Cancer 47: 399-406, 1983.
35. Ramshaw IA, Carlsen S, Wang HC: The use of cell fusion to analyze factors involved in tumor cell metastasis. Int J Cancer 32: 471-478, 1983.
36. Sobel ME: Metastasis suppressor genes. J Natl Cancer Inst 82: 267-275, 1990.
37. Dear TN, McDonald DA and Kefford RF: Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells. Cancer Res 49: 5323-5328, 1989.
38. Steeg PS, Bevilacqua G, Kopper L: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
39. Bevilacqua G, Sobel ME, Liotta LA and Steeg PA: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
40. Rosengard AM, Krutzsch HC, Shearn A: Reduced Nm23/Awd protein in tumor metastasis and aberrant Drosophila development. Nature 342: 177-180, 1989.
41. Kimura N, Shimada N, Nomura K and Watanabe K: Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. J Biol Chem 265: 15744-15749, 1990.
42. Khokha R, Waterhouse P, Yagel S, and Denhardt D: Anti-sense RNA-induced reduction in murine TIMP level confers oncogenicity on Swiss 3T3 cells. Science 243: 947-950, 1989.
43. Johnson MD, Kim H-RC and Chesler L: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194-202, 1994.
44. Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS and Zetter B: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 38: 817-823, 1997.
45. Nicolson GL, LaBiche RA, Frazier ML, Blick M., Tressler RJ, Irimura T and Rotter V Differential expression of metastasis-associated cell surface glycoproteins and mRNA in a murine large-cell lymphoma. J Cell Biochem 31: 305-312, 1986.
46. La Biche RA, Yoshida M, Gallick GE, Irimura T, Robberson DL, Klostergaard J and Nicolson GL: Gene expression and tumor cell escape from host effector mechanisms in murine large-cell lymphoma. J Cell Biochem 36: 393-403, 1988.
47. LaBiche RA, DeMars M and Nicolson GL: Transcripts of the mitochondrial gene ND5 are overexpressed in highly metastatic murine large cell lymphoma cells. In Vivo 6: 317-324, 1992.
48. 2+-binding protein family. Genes Dev 3: 1086-1093, 1989.
49. Davies BR, Davies MPA, Gibbs FEM, Barraclough R and Rudland PS: Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008, 1993.
50. Pencil SD, Toh Y, and Nicolson GL: Candidate metastasis-associated genes of rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat 25: 165-174, 1993.
51. Toh Y, Pencil SD and Nicolson GL: A novel candidate metastasis-associated gene mta1 differentially expressed in highly metastatic mammary adenocarcinoma cell lines: cDNA cloning, expression and protein analyses. J Biol Chem 269: 22958-22963, 1994.
52. Toh Y, Pencil SD and Nicolson GL: Analysis of the complete sequence of the novel gene mta1 differentially expressed in highly metastatic mammary adenocarcinoma and breast cancer cell lines and clones. Gene 159: 99-104, 1995.
53. EJ/pSV2neo or pSV2neo genes into rat mammary cells: Rapid stimulation of clonal diversification in spontaneous metastatic and cell surface properties. Oncogene 7: 1127-1135, 1992.
54. Dotto GP, El-Fouly MH, Nelson C: Similar and synergistic inhibition of gap-junctional communication by ras transformation and tumor promoter treatment of mouse primary keratinocytes. Oncogene 4: 637-641, 1989.
55. Lee SW, Tomasetto C, Sager R: Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829, 1991.
56. Pierce GB, Lewis SH, Militer GJ: Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy in blastocysts. Proc Natl Acad Sci USA 76: 6649-6655, 1979.
57. Tonegawa S: Somatic generation of antibody diversity. Nature 302: 575-581, 1983.